Effect of SARS-CoV-2 infection on HBV-infected patients: Reactivation
Background: Hepatic manifestations of COVID-19 are prevalent in individuals infected with viral hepatitis type B (HBV). Objectives: The current study aims to determine the extent of the HBV reactivation depending on the immune impact on patients infected with SARS-CoV-2. Materials and Methods: One h...
Main Authors: | Laith A I K Al-Kaif, Mohammad Abd-Kadhum Al-Saadi, Alaa H Al-Charrakh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Medical Journal of Babylon |
Subjects: | |
Online Access: | http://www.medjbabylon.org/article.asp?issn=1812-156X;year=2022;volume=19;issue=4;spage=736;epage=746;aulast=Al-Kaif |
Similar Items
-
Persistent Hepatitis B Viraemia with Polymerase Mutations among HIV/HBV Co-Infected Patients on HBV-Active ART in KwaZulu-Natal, South Africa
by: Nokukhanya Msomi, et al.
Published: (2022-04-01) -
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation
by: Lorenzo Piermatteo, et al.
Published: (2021-09-01) -
HIV/HBV Coinfection with HBsAg Seroconversion: A Case Report
by: Yasemin ÇAKIR, et al.
Published: (2024-03-01) -
Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report
by: Jürgen Kurt Rockstroh, et al.
Published: (2010-07-01) -
Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury
by: Yong Lin, et al.
Published: (2021-07-01)